will cigna cover semaglutide stop covering GLP-1 weight-loss drugs including Wegovy and Zepbound in its ​employee health plan effective July 1, according to Reuters See How Gabriela Lost Weight

Only a licensed healthcare provider can determine whether GLP-1 treatment is appropriate based on individual health needs

Still, the anti-inflammatory potential seen in other conditions provides a basis for optimism, even if more evidence is needed

While Novo Nordisk provides warning labels about common side effects of their liraglutide medications, their labels may not have provided adequate warnings about severe health risks such as stomach paralysis, intestinal blockages, bowel obstruction, or frequent and excessive vomiting

Non-insulin drugs to treat hyperglycaemia in type 1 diabetes mellitus

The consistent growth in deal size underscores the high stakes and escalating competition in the obesity drug market

Hyperglycemia also provokes the formation of cellular reactive oxygen species (ROS), resulting in secondary complications during diabetes mellitus [4,5,6]